Convertibles Calendar: Amphastar Pharmaceuticals on deck

Sept. 12

AMPHASTAR PHARMACEUTICALS INC.

• $300 million long five-year convertible notes

• $45 million greenshoe

• Coupon of 1.5% to 2% and initial conversion premium of 30% to 35%

• Rule 144A

• Jefferies LLC (lead left), BofA Securities Inc., Wells Fargo Securities LLC and J.P. Morgan Securities LLC

• Approximately $200 million of proceeds to repay borrowings under its term loan, $50 million to repurchase common stock in privately negotiated transactions and general corporate purposes

• Rancho Cucamonga, Calif.-based specialty pharmaceutical company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.